elan

Medical imaging and diagnostics powerhouse GE Healthcare teams up with pharmaceutical giant Johnson & Johnson to research methods of detecting Alzheimer's in patients -- even before they begin to exhibit symptoms of the devastating disease.

Just because a drug has managed to successfully meet earlier trial goals, it's no guarantee it will continue to do so. On Tuesday, Gilead, Elan and Transition Therapeutics halted trials of experimental drugs that had previously showed promising results. Elan Corp. (ELN) and Transition Therapeutics...

Two of the drug industry's bigger names -- Johnson & Johnson (JNJ) and Abbott Labs (ABT) -- managed to top Wall Street's profit expectations for third quarter earnings this week, revealing that diversification in product portfolios helped their bottom lines. But the better-than-expected results...

Novartis AG (NVS) announced Wednesday that a two-year Phase III study involving more than 4,000 patients worldwide shows that a new drug significantly reduces relapses and disability progression of multiple sclerosis. The chronic, irreversible disease attacks the central nervous system and is...

Elan Corp. (ELN)'s share price popped over 20 percent earlier today, but by the afternoon was up "only" over 13 percent. Still, not bad at all considering markets are down about 2 percent. The Irish drugmaker and Johnson & Johnson (JNJ) announced today they have signed a deal giving J&J...